Whittling down Prostate July 6, 2023 There are few scenarios with more data and less clarity than when to add androgen deprivation therapy (ADT) to definitive…
Still relevant Prostate May 26, 2023 While there may remain some debate over who qualifies for PSMA-(re)staging scans, most insurances will agree to it upon biochemical…
Negative outcomes Prostate May 11, 2023 Salvage radiation is still considered standard of care for patients with biochemical recurrence after prostatectomy even when PET imaging is…
Lost and found Prostate March 10, 2023 Top Line: Prior to PSMA PET, it was difficult to localize sources of biochemical failure after primary radiation for prostate…
Clarifying the vision Prostate Radiopharmaceuticals May 27, 2022 The VISION trial showed that Lu-177-PSMA-617 improved survival when added to standard treatment of men with PSMA-positive metastatic castrate-resistant prostate…
